3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Colorectal Neoplasms
19
Carcinoma, Non-Small-Cell Lung
19
Breast Neoplasms
17
Lung Neoplasms
15
Colonic Neoplasms
11
Head and Neck Neoplasms
9
Rectal Neoplasms
7
Glioblastoma
5
Prostatic Neoplasms
4
Precancerous Conditions
4
Mouth Neoplasms
4
Esophageal Neoplasms
4
Central Nervous System Neoplasms
4
Adenomatous Polyposis Coli
4
Uterine Cervical Neoplasms
3
Unspecified Adult Solid Tumor, Protocol Specific
3
Sarcoma
3
Neuroblastoma
3
Neoplasms
3
Liver Neoplasms
3
Gliosarcoma
3
Glioma
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Smoking
2
Salivary Gland Neoplasms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Neoplasms
2
Multiple Myeloma
2
Interventions
pembrolizumab
3
Ipilimumab
2
Blood Specimen Collection
2
spartalizumab
1
necitumumab
1
mirdametinib
1
leronlimab
1
apatinib
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Rosuvastatin Calcium
1
Radiotherapy
1
Radiation
1
Positron-Emission Tomography
1
PankoMab-GEX
1
Panitumumab
1
Nivolumab
1
Metformin
1
Magnetic Resonance Imaging
1
MEK inhibitor I
1
Jupiter
1
JPT1 protein, human
1
Interleukin-2
1
Immune Checkpoint Inhibitors
1
GAT
1
Fluorodeoxyglucose F18
1
FCN-437c
1
EBI-005
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Solid Tumor, Adult
×
Celecoxib
×
Clear all
NCT03728179
2024-02-20
RACIN
Centre Hospitalier Universitaire Vaudois
Phase 1
Completed
40 enrolled